Interlocked supramolecular glycoconjugated polymers for receptor-targeting theranostics

Area of Science:

• Supramolecular chemistry
• Polymer science
• Bioconjugation chemistry
• Cancer theranostics

Background:

• Conjugated polymers (CPs) offer unique optical and electronic properties for biomedical applications.
• Glycoprobes are crucial for specific cell targeting, particularly in cancer detection.
• Theranostics aims to integrate therapeutic and diagnostic capabilities for improved patient outcomes.

Purpose of the Study:

• To develop an interlocked supramolecular ensemble for enhanced cancer cell targeting.
• To investigate the theranostic potential of a conjugated polymer-glycoprobe system.
• To create a platform for simultaneous imaging and treatment of cancer cells.

Main Methods:

• Formation of a supramolecular ensemble via non-covalent interactions between a conjugated polymer and a fluorescent glycoprobe.
• Characterization of the ensemble's structure and properties using spectroscopic and microscopic techniques.
• In vitro evaluation of receptor-targeting efficiency and theranostic efficacy in cancer cell lines.

Main Results:

• Successfully formed a stable interlocked supramolecular ensemble.
• Demonstrated specific binding and uptake by receptor-expressing cancer cells.
• Showcased the potential for fluorescence-guided imaging and targeted therapy.

Conclusions:

• The developed supramolecular ensemble represents a promising platform for receptor-targeting cancer theranostics.
• Integration of conjugated polymers and glycoprobes enables synergistic therapeutic and diagnostic functions.
• This approach offers a novel strategy for advancing precision cancer medicine.